Extended duration of the detectable stage by adding HPV test in cervical cancer screening

The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a st...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Akker-van Marie, M E, van Ballegooijen, M, Rozendaal, L, Meijer, C J L M, Habbema, J D F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394464/
https://www.ncbi.nlm.nih.gov/pubmed/14612887
http://dx.doi.org/10.1038/sj.bjc.6601355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394464/
https://www.ncbi.nlm.nih.gov/pubmed/14612887
http://dx.doi.org/10.1038/sj.bjc.6601355

Ejemplares similares